SR144528
SIGMA/SML1899 - ≥98% (HPLC)
Synonym: 5-
CAS Number: 192703-06-3
Empirical Formula (Hill Notation): C29H34ClN3O
Molecular Weight: 476.05
MDL Number: MFCD05662316
Linear Formula: C29H34ClN3O
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C29H34ClN3O/c1-18-6-8- |
| InChI key | SUGVYNSRNKFXQM-XRHWURSXSA |
| Quality Level | 100 ![]() |
| SMILES string | C[C@]12[C@H](NC(C3=NN(CC4 |
| solubility | DMSO: 10 mg/mL, clear |
| storage temp. | −20°C |
| Application: | SR144528 has been used as a cannabinoid CB2 receptor antagonist: • to study its blocking effect on the anti-dyskinetic functionality of HU-308 • to study its effects on spontaneous excitatory postsynaptic currents (sEPSCs) from the globus pallidus neurons • to analyze its effect on the gastric emptying in rats |
| Biochem/physiol Actions: | SR144528 is a potent and highly selective cannabinoid CB2 receptor inverse agonist. |
| Biochem/physiol Actions: | SR144528 is a potent and highly selective cannabinoid CB2 receptor inverse agonist. SR144528 exhibited a Ki of 0.6 nM at CB2 compared to 400 nM at the related CB1 receptor. |
| Packaging: | 5, 25 mg in glass bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Purity | ≥98% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |

